Przepiorka D, Weisdorf D, Martin P, Klingemann H G, Beatty P, Hows J, Thomas E D
University of Texas MD Anderson Cancer Center, Houston 77030, USA.
Bone Marrow Transplant. 1995 Jun;15(6):825-8.
Grading acute graft-versus-host disease (GVHD) is usually based on quantification of rash, serum bilirubin and diarrhea. Standard criteria have been developed and used for > 20 years by most transplant centers. However, neither the standard GVHD grading system nor any of several revisions has been validated in the context of GVHD prophylaxis with cyclosporine. The 1994 Consensus Conference on Acute GVHD Grading held in Keystone in January 1994 provided an opportunity to: (1) review data regarding these standard criteria; (2) determine if there are sufficient data to revise these criteria; and (3) develop recommendations for reporting results of GVHD prevention trials. Data were provided for 8249 patients from 12 large transplant centers and 2 transplant registries. Standard GVHD grading criteria were found to distinguish different mortality risks and treatment response rates. Analysis of new data suggested that persistent nausea with histologic evidence of GVHD but no diarrhea be included as stage 1 gastrointestinal GVHD. Additional studies were recommended to evaluate heterogeneity of outcome within GVHD grades prior to making further revisions. To improve comparability between publications, reports of GVHD prevention trials should include an accurate description of the grading system used and should report actuarial rates of grades II-IV and III-IV GVHD corrected for graft failure and potential interventions for early relapse. Additional information should include indications for therapy of GVHD and response.
急性移植物抗宿主病(GVHD)的分级通常基于皮疹、血清胆红素和腹泻的量化评估。多数移植中心已经制定并使用标准标准20多年了。然而,无论是标准的GVHD分级系统还是其多个修订版本,均未在环孢素预防GVHD的背景下得到验证。1994年1月在基斯通召开的急性GVHD分级共识会议提供了一个机会:(1)回顾有关这些标准标准的数据;(2)确定是否有足够的数据来修订这些标准;(3)制定关于报告GVHD预防试验结果的建议。来自12个大型移植中心和2个移植登记处的8249例患者的数据被提供。发现标准的GVHD分级标准能够区分不同的死亡风险和治疗反应率。对新数据的分析表明,伴有GVHD组织学证据但无腹泻的持续性恶心应列为1级胃肠道GVHD。建议在进行进一步修订之前开展更多研究,以评估GVHD分级内结局的异质性。为提高不同出版物之间的可比性,GVHD预防试验报告应准确描述所使用的分级系统,并应报告经移植失败校正的II-IV级和III-IV级GVHD的精算发生率以及早期复发的潜在干预措施。其他信息应包括GVHD治疗的指征和反应。